A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalitiesJoanne Quan, Michael W. Konstan, Judy P. Sy et al.|The Journal of Pediatrics|2001Cited by 302